Juan A. Garcia-Velasco , Paola Viganò , Edgardo Somigliana
{"title":"Twenty-five years of research in endometriosis","authors":"Juan A. Garcia-Velasco , Paola Viganò , Edgardo Somigliana","doi":"10.1016/j.rbmo.2025.104830","DOIUrl":null,"url":null,"abstract":"<div><div>Research rarely progresses in a straight line. It is more like an unpredictable front, marked by bursts of brilliance that fade after a few years, sudden breakthroughs, periods of stagnation, rediscoveries of forgotten ideas and occasional setbacks. Endometriosis research is no exception to these dynamics. In this opinion piece, three Generation X researchers who have been dedicated to endometriosis since the early days of their careers reflect on the field's progress over the past 25 years. Their verdict? Not disappointing. In fact, some pivotal strides have been made. The understanding of endometriosis has undergone a dramatic transformation. Hormonal therapies and assisted reproductive technology have emerged as first-line treatments, dethroning the once-central role of surgery. Non-invasive diagnosis of the disease has spread. This shift marks a notable evolution in how the disease is managed. However, high-throughput technologies have failed to deliver transformative insights, and the root causes of the disease remain as elusive as ever. Despite the setbacks, the progress made offers hope and direction.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"50 4","pages":"Article 104830"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive biomedicine online","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1472648325000379","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Research rarely progresses in a straight line. It is more like an unpredictable front, marked by bursts of brilliance that fade after a few years, sudden breakthroughs, periods of stagnation, rediscoveries of forgotten ideas and occasional setbacks. Endometriosis research is no exception to these dynamics. In this opinion piece, three Generation X researchers who have been dedicated to endometriosis since the early days of their careers reflect on the field's progress over the past 25 years. Their verdict? Not disappointing. In fact, some pivotal strides have been made. The understanding of endometriosis has undergone a dramatic transformation. Hormonal therapies and assisted reproductive technology have emerged as first-line treatments, dethroning the once-central role of surgery. Non-invasive diagnosis of the disease has spread. This shift marks a notable evolution in how the disease is managed. However, high-throughput technologies have failed to deliver transformative insights, and the root causes of the disease remain as elusive as ever. Despite the setbacks, the progress made offers hope and direction.
期刊介绍:
Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.
Context:
The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.